DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 44 filers reported holding DECIBEL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,265 | +39.8% | 750 | -5.1% | 0.00% | – |
| Q4 2022 | $1,620 | -91.5% | 790 | -85.0% | 0.00% | – |
| Q3 2022 | $19,000 | -58.7% | 5,264 | -51.9% | 0.00% | – |
| Q2 2022 | $46,000 | -17.9% | 10,947 | -41.4% | 0.00% | – |
| Q1 2022 | $56,000 | -12.5% | 18,689 | +36.2% | 0.00% | – |
| Q4 2021 | $64,000 | -56.8% | 13,723 | -28.8% | 0.00% | – |
| Q3 2021 | $148,000 | +1380.0% | 19,273 | +1516.9% | 0.00% | – |
| Q2 2021 | $10,000 | -87.2% | 1,192 | -82.6% | 0.00% | – |
| Q1 2021 | $78,000 | – | 6,853 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,139,685 | $9,545,000 | 2.59% |
| Samsara BioCapital, LLC | 826,422 | $2,512,000 | 0.63% |
| Orbimed Advisors | 4,945,192 | $15,033,000 | 0.24% |
| Alphabet Inc. | 1,636,258 | $4,974,000 | 0.16% |
| HARVARD MANAGEMENT CO INC | 328,798 | $1,000,000 | 0.10% |
| Casdin Capital, LLC | 330,000 | $1,003,000 | 0.04% |
| Bronte Capital Management Pty Ltd. | 163,224 | $496,000 | 0.04% |
| MYDA Advisors LLC | 20,000 | $61,000 | 0.02% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 263,600 | $801,000 | 0.02% |
| ATLAS CAPITAL ADVISORS LLC | 41,025 | $124,716,000 | 0.02% |